Sequana Medical NV reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was EUR 0.712 million compared to EUR 0.923 million a year ago. Net loss was EUR 32.56 million compared to EUR 30.76 million a year ago.

Basic loss per share from continuing operations was EUR 1.22 compared to EUR 1.35 a year ago.